Detalhe da pesquisa
1.
Hepatitis C virus genotypes distribution and transmission risk factors in Luxembourg from 1991 to 2006.
World J Gastroenterol
; 14(8): 1237-43, 2008 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-18300350
2.
A new recombinant virus system for the study of HIV-1 entry and inhibition.
J Virol Methods
; 131(1): 99-104, 2006 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-16111774
3.
Rare and new V3 loop variants in HIV-1-positive long-term non-progressors from Rwanda.
AIDS
; 16(13): 1827-9, 2002 Sep 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-12218396
4.
HIV-1 subtypes in Luxembourg, 1983-2000.
AIDS
; 16(18): 2461-7, 2002 Dec 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-12461421
5.
HIV type 1 pol gene diversity and archived nevirapine resistance mutation in pregnant women in Rwanda.
AIDS Res Hum Retroviruses
; 20(3): 279-83, 2004 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-15117451
6.
Resistance testing in children changing human immunodeficiency virus type 1 protease inhibitor.
Pediatr Infect Dis J
; 21(3): 214-20, 2002 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-12005085
7.
Prevalence of HIV co-receptor polymorphisms in HIV-infected patients and uninfected volunteers in Luxembourg.
HIV Clin Trials
; 3(3): 195-201, 2002.
Artigo
em Inglês
| MEDLINE | ID: mdl-12032878
8.
[Prevalence of transmission of methicillin resistant Staphylococcus in home care patients]. / Prévalence du portage de Staphylocoque doré résistant a la Méthicilline chez des patients soignés a domicile.
Bull Soc Sci Med Grand Duche Luxemb
; (1): 7-16, 2004.
Artigo
em Francês
| MEDLINE | ID: mdl-15543999
9.
[Recombinant virus assay: a rapid assay for assessment of drug susceptibility of human immunodeficiency virus type 1 isolates].
Zhongguo Yi Xue Ke Xue Yuan Xue Bao
; 24(5): 523-6, 2002 Oct.
Artigo
em Zh
| MEDLINE | ID: mdl-12905778
10.
Association of haptoglobin phenotypes with the development of Kaposi's sarcoma in HIV patients.
Arch Dermatol Res
; 303(10): 763-9, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21748360
11.
Infection control in the management of highly pathogenic infectious diseases: consensus of the European Network of Infectious Disease.
Lancet Infect Dis
; 9(5): 301-11, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19393960
12.
The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypes.
J Acquir Immune Defic Syndr
; 41(3): 352-60, 2006 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-16540937
13.
Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management.
J Infect Dis
; 192(6): 958-66, 2005 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16107947
14.
Longitudinal use of a line probe assay for human immunodeficiency virus type 1 protease predicts phenotypic resistance and clinical progression in patients failing highly active antiretroviral therapy.
Antimicrob Agents Chemother
; 46(6): 1928-33, 2002 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-12019110
15.
Uncommon mutations at residue positions critical for enfuvirtide (T-20) resistance in enfuvirtide-naive patients infected with subtype B and non-B HIV-1 strains.
J Acquir Immune Defic Syndr
; 33(2): 134-9, 2003 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12794544
16.
Longitudinal use of phenotypic resistance testing to HIV-1 protease inhibitors in patients developing HAART failure.
J Med Virol
; 67(3): 312-9, 2002 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-12116020